Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Processing and transcriptome expansion at the mRNA 3' end in health and disease: finding the right end.

Ogorodnikov A, Kargapolova Y, Danckwardt S.

Pflugers Arch. 2016 Jun;468(6):993-1012. doi: 10.1007/s00424-016-1828-3. Epub 2016 May 25. Review.

2.

Proteomic Analysis Reveals Branch-specific Regulation of the Unfolded Protein Response by Nonsense-mediated mRNA Decay.

Sieber J, Hauer C, Bhuvanagiri M, Leicht S, Krijgsveld J, Neu-Yilik G, Hentze MW, Kulozik AE.

Mol Cell Proteomics. 2016 May;15(5):1584-97. doi: 10.1074/mcp.M115.054056. Epub 2016 Feb 20.

PMID:
26896796
3.

Prothrombin C20209T mutation in deep vein thrombosis: a case report.

Muñoz M, Vilos C, Cantín M.

Int J Clin Exp Med. 2015 Jul 15;8(7):11225-9. eCollection 2015.

4.

The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders.

Gunathilake KM, Sirisena UN, Nisansala PK, Goonasekera HW, Jayasekara RW, Dissanayake VH.

Indian J Hematol Blood Transfus. 2015 Sep;31(3):356-61. doi: 10.1007/s12288-014-0452-7. Epub 2014 Sep 2.

5.

CPSF30 at the Interface of Alternative Polyadenylation and Cellular Signaling in Plants.

Chakrabarti M, Hunt AG.

Biomolecules. 2015 Jun 8;5(2):1151-68. doi: 10.3390/biom5021151. Review.

6.

The 3' end prothrombin gene variants in serbian patients with idiopathic thrombophilia.

Aradjanski M, Djordjevic V, Pruner I, Tomic B, Gvozdenov M, Kovac M, Radojkovic D.

Balkan J Med Genet. 2015 Apr 10;17(2):43-8. doi: 10.2478/bjmg-2014-0073. eCollection 2014 Dec.

7.

Implications of polyadenylation in health and disease.

Curinha A, Oliveira Braz S, Pereira-Castro I, Cruz A, Moreira A.

Nucleus. 2014;5(6):508-19. doi: 10.4161/nucl.36360. Epub 2014 Oct 31. Review.

8.

mRNA 3'end processing: A tale of the tail reaches the clinic.

Hollerer I, Grund K, Hentze MW, Kulozik AE.

EMBO Mol Med. 2014 Jan;6(1):16-26. doi: 10.1002/emmm.201303300. Review.

9.

Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population.

Park HJ, Kim SK, Kim JW, Lee SH, Yoo KH, Chung JH.

Dis Markers. 2013;35(6):869-75. doi: 10.1155/2013/792941. Epub 2013 Dec 9.

10.

Genome-wide analysis of poly(A) site selection in Schizosaccharomyces pombe.

Schlackow M, Marguerat S, Proudfoot NJ, Bähler J, Erban R, Gullerova M.

RNA. 2013 Dec;19(12):1617-31. doi: 10.1261/rna.040675.113. Epub 2013 Oct 23.

11.

Propagation of genetic variation in gene regulatory networks.

Plahte E, Gjuvsland AB, Omholt SW.

Physica D. 2013 Aug 1;256-257:7-20.

12.

Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond.

Danckwardt S, Hentze MW, Kulozik AE.

J Mol Med (Berl). 2013 Nov;91(11):1257-71. doi: 10.1007/s00109-013-1074-5. Epub 2013 Aug 17. Review.

13.

Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders.

Michalova E, Vojtesek B, Hrstka R.

Int J Mol Sci. 2013 Jul 26;14(8):15681-94. doi: 10.3390/ijms140815681. Review.

14.

Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H.

Hum Genet. 2013 Oct;132(10):1077-130. doi: 10.1007/s00439-013-1331-2. Epub 2013 Jul 3. Review.

15.

Alterations in polyadenylation and its implications for endocrine disease.

Rehfeld A, Plass M, Krogh A, Friis-Hansen L.

Front Endocrinol (Lausanne). 2013 May 8;4:53. doi: 10.3389/fendo.2013.00053. eCollection 2013.

16.

Gene-gene interaction and functional impact of polymorphisms on innate immune genes in controlling Plasmodium falciparum blood infection level.

Basu M, Das T, Ghosh A, Majumder S, Maji AK, Kanjilal SD, Mukhopadhyay I, Roychowdhury S, Banerjee S, Sengupta S.

PLoS One. 2012;7(10):e46441. doi: 10.1371/journal.pone.0046441. Epub 2012 Oct 12.

17.

Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.

Giudicessi JR, Ackerman MJ.

Transl Res. 2013 Jan;161(1):1-14. doi: 10.1016/j.trsl.2012.08.005. Epub 2012 Sep 17. Review.

18.

Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.

Scartozzi M, Loretelli C, Galizia E, Mandolesi A, Pistelli M, Bittoni A, Giampieri R, Faloppi L, Bianconi M, Del Prete M, Bianchi F, Belvederesi L, Bearzi I, Cascinu S.

PLoS One. 2012;7(7):e38192. doi: 10.1371/journal.pone.0038192. Epub 2012 Jul 9.

19.

A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer.

Luo J, Cai Q, Wang W, Huang H, Zeng H, He W, Deng W, Yu H, Chan E, Ng CF, Huang J, Lin T.

PLoS One. 2012;7(6):e40127. doi: 10.1371/journal.pone.0040127. Epub 2012 Jun 29.

20.

Hereditary thrombophilic risk factors for recurrent pregnancy loss.

Bogdanova N, Markoff A.

J Community Genet. 2010 Jun;1(2):47-53. doi: 10.1007/s12687-010-0011-3. Epub 2010 Jun 11.

Items per page

Supplemental Content

Write to the Help Desk